๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

โœ Scribed by Brown, David M.; Kaiser, Peter K.; Michels, Mark; Soubrane, Gisele; Heier, Jeffrey S.; Kim, Robert Y.; Sy, Judy P.; Schneider, Susan

Book ID
120020612
Publisher
Massachusetts Medical Society
Year
2006
Tongue
English
Weight
324 KB
Volume
355
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ranibizumab for Neovascular Age-Related
Ranibizumab for Neovascular Age-Related Macular Degeneration
โœ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha